Rate of decline of lung function in subjects with asthma
- PMID: 3569449
Rate of decline of lung function in subjects with asthma
Abstract
Retrospective and prospective questionnaire and lung function data, collected during seven population health surveys over 18 years in Busselton, Western Australia, have been analysed for 92 subjects with asthma and 186 normal subjects. Subjects who had a minimum of four observations over an 18-year period were selected; the age range at first study was 22-69 years. Individual regression analyses of forced expiratory volume in one second (FEV1), adjusted for height, on age were used in analyses. Subjects with asthma had a greater rate of decline in FEV1 (p less than 0.01) and a lower baseline lung function (p less than 0.001). The mean loss of FEV1 in males of 1.7 m height was 50 ml/year in nonsmokers with asthma compared with 35 ml/year in the normal subjects. The effect of asthma was variable and not all subjects with asthma had steep rates of decline. There were insufficient numbers of smokers with asthma to draw conclusions about an effect of cigarette smoking additional to the effect of asthma. No relationship was found between rate of decline of FEV1 and age or atopic status. In subjects with asthma, bronchial hyperresponsiveness, which was measured at the end of the study, accounted for 9% of the variation in rate of decline of FEV1 and airflow limitation, measured by FEV1 FVC, accounted for 10%. Further studies are needed to determine whether the steep rates of decline found in subjects with asthma are preventable.
Similar articles
-
Serum interferon-gamma is associated with longitudinal decline in lung function among asthmatic patients: the Normative Aging Study.Ann Allergy Asthma Immunol. 2003 Apr;90(4):422-8. doi: 10.1016/S1081-1206(10)61827-3. Ann Allergy Asthma Immunol. 2003. PMID: 12722965
-
The association between baseline lung function and bronchial responsiveness to methacholine.Eur J Med Res. 1997 Feb 21;2(2):47-54. Eur J Med Res. 1997. PMID: 9085014 Clinical Trial.
-
Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.Br J Gen Pract. 1996 Jan;46(402):15-8. Br J Gen Pract. 1996. PMID: 8745846 Free PMC article. Clinical Trial.
-
[Lung health in middle age. Screening of 40-year old persons in Vest-Agder].Tidsskr Nor Laegeforen. 1991 Jun 10;111(15):1834-9. Tidsskr Nor Laegeforen. 1991. PMID: 1853313 Review. Norwegian.
-
Prospective investigations in asthma. What have we learned from longitudinal studies about lung growth and senescence in asthma?Chest. 1987 Jun;91(6 Suppl):119S-126S. Chest. 1987. PMID: 3556061 Review.
Cited by
-
Reduction in mouse allergen exposure is associated with greater lung function growth.J Allergy Clin Immunol. 2020 Feb;145(2):646-653.e1. doi: 10.1016/j.jaci.2019.08.043. Epub 2019 Dec 19. J Allergy Clin Immunol. 2020. PMID: 31866099 Free PMC article. Clinical Trial.
-
Respiratory syncytial virus and reactive airway disease.Curr Top Microbiol Immunol. 2013;372:105-18. doi: 10.1007/978-3-642-38919-1_5. Curr Top Microbiol Immunol. 2013. PMID: 24362686 Free PMC article.
-
Clinical expression of airway hyperreactivity in adults.Clin Rev Allergy. 1989 Fall;7(3):321-43. doi: 10.1007/BF02914481. Clin Rev Allergy. 1989. PMID: 2676136 Review. No abstract available.
-
Pharmacotherapy and airway remodelling in asthma?Thorax. 2003 Feb;58(2):163-74. doi: 10.1136/thorax.58.2.163. Thorax. 2003. PMID: 12554904 Free PMC article. Review.
-
Longitudinal decline in lung function in patients with occupational asthma due to western red cedar.Occup Environ Med. 1996 Nov;53(11):753-6. doi: 10.1136/oem.53.11.753. Occup Environ Med. 1996. PMID: 9038799 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical